AI Clinical Trials innovation network (ACTin), Solotrials

Goals: Reduce inflated drug to market length and cost. Empower patients. Increase public awareness & access to clinical trials using technology. Promote and utilize technology AI/ML/DL/RL etc. to optimize clinical trial input [sample size, reference, controls, variables, etc.] & clinical trial related patient data. Increase awareness of digital health benefits and opportunities among healthcare providers, allies, stakeholders, public. Promote sustainable, viable healthcare growth & innovation. Increase quality of life and quality of care. Integration of AI/ML et al. & curated distributional semantic data correlated to real time evidence based medicine (EBM), systematic literature review & corresponding input data. The optimization of diagnostic & therapeutic decision making utilized Point of Care Testing, POCT & other emerging biomedical diagnostic technologies & devices. Utilize AI/ML et al. to efficiently guide rational drug design. Increase & Innovate clinical trial access, efficiency & experience for all involved. Use emerging data analytics ethically to improve quality of life & quality of care. Reduce health system stress & caregiver burnout.